• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐红霉素及缺乏百日咳杆菌黏附素和丝状血凝素菌株的出现——中国北京,2022年至2023年

Emergence of Erythromycin-Resistant and Pertactin- and Filamentous Hemagglutinin-Deficient Strains - Beijing, China, 2022-2023.

作者信息

Zhou Guilan, Li Ying, Wang Hairui, Wang Yuanyuan, Gao Yuan, Xu Juan, Wang Fengshuang, Peng Tao, Zhang Maojun, Shao Zhujun

机构信息

National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Shunyi District Center for Disease Control and Prevention, Beijing, China.

出版信息

China CDC Wkly. 2024 May 17;6(20):437-441. doi: 10.46234/ccdcw2024.085.

DOI:10.46234/ccdcw2024.085
PMID:38846358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11150165/
Abstract

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC?: Pertussis has reemerged as a significant public health threat, primarily due to variations in strains, antimicrobial resistance, and vaccine evasion.

WHAT IS ADDED BY THIS REPORT?: All isolated strains were identified as type and exhibited resistance to erythromycin. Two strains showed a deficiency in Fha, thirty in Prn, and one strain exhibited multiple immunogen deficiencies.

WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE?: The emergence and spread of immunogen-deficient strains likely result from prolonged vaccine selection pressure, posing challenges to the efficacy of pertussis vaccines. Additionally, the ongoing dissemination of strains with high-level macrolide resistance presents a significant obstacle to clinical treatment strategies.

摘要

关于该主题已知的信息有哪些?:百日咳已再次成为重大的公共卫生威胁,主要是由于菌株变异、抗菌药物耐药性和疫苗逃逸。

本报告补充了哪些内容?:所有分离出的菌株均被鉴定为 型,并对红霉素耐药。两株菌株显示Fha缺乏,30株Prn缺乏,一株菌株表现出多种免疫原缺乏。

对公共卫生实践有哪些影响?:免疫原缺陷菌株的出现和传播可能是长期疫苗选择压力导致的,对百日咳疫苗的效力构成挑战。此外,高水平大环内酯类耐药菌株的持续传播对临床治疗策略构成重大障碍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f6/11150165/cb9d8926cdc3/ccdcw-6-20-437-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f6/11150165/b851aaadf22a/ccdcw-6-20-437-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f6/11150165/ea003709b652/ccdcw-6-20-437-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f6/11150165/cb9d8926cdc3/ccdcw-6-20-437-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f6/11150165/b851aaadf22a/ccdcw-6-20-437-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f6/11150165/ea003709b652/ccdcw-6-20-437-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48f6/11150165/cb9d8926cdc3/ccdcw-6-20-437-3.jpg

相似文献

1
Emergence of Erythromycin-Resistant and Pertactin- and Filamentous Hemagglutinin-Deficient Strains - Beijing, China, 2022-2023.耐红霉素及缺乏百日咳杆菌黏附素和丝状血凝素菌株的出现——中国北京,2022年至2023年
China CDC Wkly. 2024 May 17;6(20):437-441. doi: 10.46234/ccdcw2024.085.
2
A Cross-Sectional Study Revealing the Emergence of Erythromycin-Resistant Carrying Alleles in China.一项揭示中国红霉素耐药携带等位基因出现情况的横断面研究。
Front Microbiol. 2022 Jul 18;13:901617. doi: 10.3389/fmicb.2022.901617. eCollection 2022.
3
Sequence variation in virulence-related genes of Bordetella pertussis isolates from Poland in the period 1959-2013.1959年至2013年期间波兰百日咳博德特氏菌分离株毒力相关基因的序列变异
Eur J Clin Microbiol Infect Dis. 2015 Jan;34(1):147-152. doi: 10.1007/s10096-014-2216-6. Epub 2014 Aug 5.
4
Molecular epidemiology of Bordetella pertussis and analysis of vaccine antigen genes from clinical isolates from Shenzhen, China.中国深圳临床分离株百日咳博德特氏菌的分子流行病学和疫苗抗原基因分析。
Ann Clin Microbiol Antimicrob. 2021 Aug 18;20(1):53. doi: 10.1186/s12941-021-00458-3.
5
Emergence and spread of MT28 ptxP3 allele macrolide-resistant Bordetella pertussis from 2021 to 2022 in China.2021年至2022年中国MT28 ptxP3等位基因大环内酯类耐药百日咳博德特氏菌的出现与传播
Int J Infect Dis. 2023 Mar;128:205-211. doi: 10.1016/j.ijid.2023.01.005. Epub 2023 Jan 9.
6
Molecular Evolution and Increasing Macrolide Resistance of Bordetella pertussis, Shanghai, China, 2016-2022.2016-2022 年中国上海百日咳博德特氏菌的分子进化和大环内酯类耐药性增加。
Emerg Infect Dis. 2023 Jan;30(1):29-38. doi: 10.3201/eid3001.221588.
7
Pertussis upsurge, age shift and vaccine escape post-COVID-19 caused by ptxP3 macrolide-resistant Bordetella pertussis MT28 clone in China.中国 ptxP3 大环内酯类耐药博德特氏菌 MT28 克隆引起的 COVID-19 后百日咳疫情抬头、年龄偏移和疫苗逃逸。
Clin Microbiol Infect. 2024 Nov;30(11):1439-1446. doi: 10.1016/j.cmi.2024.08.016. Epub 2024 Aug 28.
8
Pertactin-deficient Bordetella pertussis isolates in Poland-a country with whole-cell pertussis primary vaccination.波兰全细胞百日咳疫苗初免国家中 pertactin 缺陷型百日咳博德特氏菌分离株。
Microbes Infect. 2019 Apr-May;21(3-4):170-175. doi: 10.1016/j.micinf.2018.12.001. Epub 2018 Dec 21.
9
Domination of an emerging erythromycin-resistant ptxP3 Bordetella pertussis clone in Shanghai, China.中国上海新兴红霉素耐药 ptxP3 博德特氏菌克隆的主导地位。
Int J Antimicrob Agents. 2023 Jul;62(1):106835. doi: 10.1016/j.ijantimicag.2023.106835. Epub 2023 Apr 30.
10
Variation in Bordetella pertussis Susceptibility to Erythromycin and Virulence-Related Genotype Changes in China (1970-2014).中国百日咳博德特氏菌对红霉素的敏感性及毒力相关基因型变化(1970 - 2014年)
PLoS One. 2015 Sep 25;10(9):e0138941. doi: 10.1371/journal.pone.0138941. eCollection 2015.

引用本文的文献

1
Macrolide-Resistant in Hong Kong: Evidence for Post-COVID-19 Emergence of -Lineage MT28 Clone from a Hospital-Based Surveillance Study.香港的大环内酯类耐药性:一项基于医院监测研究的新冠疫情后出现的MT28谱系克隆的证据。
Microorganisms. 2025 Aug 20;13(8):1947. doi: 10.3390/microorganisms13081947.
2
Molecular epidemiology and genomic features of Bordetella pertussis in Tianjin, China, 2023.2023年中国天津百日咳博德特氏菌的分子流行病学及基因组特征
BMC Microbiol. 2025 Aug 23;25(1):534. doi: 10.1186/s12866-025-04276-x.
3
Global, regional, and national burdens of pertussis among adults: a systematic analysis of age-specific trends using Global Burden of Diseases 2021 data.

本文引用的文献

1
Domination of an emerging erythromycin-resistant ptxP3 Bordetella pertussis clone in Shanghai, China.中国上海新兴红霉素耐药 ptxP3 博德特氏菌克隆的主导地位。
Int J Antimicrob Agents. 2023 Jul;62(1):106835. doi: 10.1016/j.ijantimicag.2023.106835. Epub 2023 Apr 30.
2
Genomic dissection of the microevolution of Australian epidemic .澳大利亚流行病毒的微进化的基因组剖析。
Emerg Microbes Infect. 2022 Dec;11(1):1460-1473. doi: 10.1080/22221751.2022.2077129.
3
High Prevalence of Macrolide-Resistant Bordetella pertussis and ptxP1 Genotype, Mainland China, 2014-2016.
成人百日咳的全球、区域和国家负担:利用《2021年全球疾病负担》数据对特定年龄趋势进行的系统分析。
Infect Dis Poverty. 2025 Aug 11;14(1):85. doi: 10.1186/s40249-025-01355-z.
4
[Potential impact of adjusting immunization procedure for diphtheria-tetanus-pertussis vaccine on pertussis in clinical practice].调整白喉-破伤风-百日咳疫苗免疫程序对临床实践中百日咳的潜在影响
Zhongguo Dang Dai Er Ke Za Zhi. 2025 Jul 15;27(7):786-791. doi: 10.7499/j.issn.1008-8830.2501077.
5
Waning immunity, prevailing non-vaccine type and macrolide-resistant strains in the 2024 pertussis outbreak in China: a multicentre cross-sectional descriptive study.中国2024年百日咳疫情中的免疫衰退、流行的非疫苗型及大环内酯类耐药菌株:一项多中心横断面描述性研究
Lancet Reg Health West Pac. 2025 Jul 4;60:101628. doi: 10.1016/j.lanwpc.2025.101628. eCollection 2025 Jul.
6
The potential of wastewater monitoring as a novel surveillance tool for early warning of outbreaks.废水监测作为疫情早期预警新型监测工具的潜力。
Emerg Microbes Infect. 2025 Dec;14(1):2528537. doi: 10.1080/22221751.2025.2528537. Epub 2025 Jul 10.
7
Pertussis in the Post-COVID-19 Era: Resurgence, Diagnosis, and Management.新冠疫情后时代的百日咳:卷土重来、诊断与管理
Infect Chemother. 2025 Mar;57(1):13-30. doi: 10.3947/ic.2024.0117.
8
Sharp rise in high-virulence Bordetella pertussis with macrolides resistance in Northern China.中国北方高毒力百日咳博德特氏菌对大环内酯类药物耐药性急剧上升。
Emerg Microbes Infect. 2025 Dec;14(1):2475841. doi: 10.1080/22221751.2025.2475841. Epub 2025 Mar 18.
9
Molecular epidemiology and genomic features of in Shanghai, China, 2017-2022.2017 - 2022年中国上海[具体研究对象]的分子流行病学及基因组特征
Front Microbiol. 2024 Jul 9;15:1428766. doi: 10.3389/fmicb.2024.1428766. eCollection 2024.
2014-2016 年中国大陆地区大环内酯类耐药百日咳博德特氏菌流行率高及 ptxP1 基因型占主导地位。
Emerg Infect Dis. 2019 Dec;25(12):2205-2214. doi: 10.3201/eid2512.181836.
4
Genomic epidemiology of erythromycin-resistant Bordetella pertussis in China.中国红霉素耐药百日咳博德特氏菌的基因组流行病学研究。
Emerg Microbes Infect. 2019;8(1):461-470. doi: 10.1080/22221751.2019.1587315.
5
Bordetella pertussis Infection in Infants and Young Children in Shanghai, China, 2016-2017: Clinical Features, Genotype Variations of Antigenic Genes and Macrolides Resistance.中国上海 2016-2017 年婴幼儿百日咳鲍特菌感染:临床特征、抗原基因的基因型变异及大环内酯类耐药性。
Pediatr Infect Dis J. 2019 Apr;38(4):370-376. doi: 10.1097/INF.0000000000002160.
6
Quantitative determination of bioactive proteins in diphtheria tetanus acellular pertussis (DTaP) vaccine by liquid chromatography tandem mass spectrometry.采用液相色谱-串联质谱法定量测定白喉破伤风无细胞百日咳(DTaP)疫苗中的生物活性蛋白。
J Pharm Biomed Anal. 2019 May 30;169:30-40. doi: 10.1016/j.jpba.2019.02.029. Epub 2019 Feb 21.
7
Screening and Genomic Characterization of Filamentous Hemagglutinin-Deficient Bordetella pertussis.筛查和丝状血凝素缺陷百日咳博德特氏菌的基因组特征分析。
Infect Immun. 2018 Mar 22;86(4). doi: 10.1128/IAI.00869-17. Print 2018 Apr.
8
Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.美国百日咳杆菌中缺乏丝状血凝素的百日咳博德特氏菌的流行情况及分子特征
Clin Vaccine Immunol. 2014 Feb;21(2):119-25. doi: 10.1128/CVI.00717-13. Epub 2013 Nov 20.
9
Bordetella pertussis strains with increased toxin production associated with pertussis resurgence.毒素产生增加的百日咳博德特氏菌菌株与百日咳的再度流行有关。
Emerg Infect Dis. 2009 Aug;15(8):1206-13. doi: 10.3201/eid1508.081511.
10
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.百日咳博德特氏菌及其他博德特氏菌亚种引起的呼吸道感染的分子发病机制、流行病学及临床表现
Clin Microbiol Rev. 2005 Apr;18(2):326-82. doi: 10.1128/CMR.18.2.326-382.2005.